Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Apply
Dostarlimab
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step